STOKE THERAPEUTICS INC's ticker is STOK and the CUSIP is 86150R107. A total of 108 filers reported holding STOKE THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is 0.29 and the average weighting 0.5%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $548,911 | +8.9% | 40,630 | +8.8% | 0.00% | – |
Q1 2024 | $504,090 | +156.7% | 37,340 | 0.0% | 0.00% | – |
Q4 2023 | $196,408 | +20.6% | 37,340 | -9.6% | 0.00% | – |
Q3 2023 | $162,801 | -62.9% | 41,320 | 0.0% | 0.00% | – |
Q2 2023 | $439,232 | +51.5% | 41,320 | +18.7% | 0.00% | – |
Q1 2023 | $289,884 | +3.3% | 34,800 | +14.5% | 0.00% | – |
Q4 2022 | $280,592 | -20.5% | 30,400 | +10.5% | 0.00% | – |
Q3 2022 | $353,000 | +12.8% | 27,500 | +16.0% | 0.00% | – |
Q2 2022 | $313,000 | -24.9% | 23,700 | +19.7% | 0.00% | – |
Q1 2022 | $417,000 | -12.2% | 19,800 | 0.0% | 0.00% | – |
Q4 2021 | $475,000 | +0.4% | 19,800 | +6.5% | 0.00% | – |
Q3 2021 | $473,000 | -29.0% | 18,600 | -6.1% | 0.00% | – |
Q2 2021 | $666,000 | -5.3% | 19,800 | +9.4% | 0.00% | – |
Q1 2021 | $703,000 | -34.8% | 18,100 | +4.0% | 0.00% | -100.0% |
Q4 2020 | $1,078,000 | +55.6% | 17,400 | -15.9% | 0.00% | – |
Q3 2020 | $693,000 | +32.8% | 20,700 | -5.5% | 0.00% | – |
Q2 2020 | $522,000 | +31.8% | 21,900 | +26.6% | 0.00% | – |
Q1 2020 | $396,000 | – | 17,300 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
ATP Life Science Ventures, L.P. | 16,786,713 | $475,340,000 | 79.82% |
RTW INVESTMENTS, LP | 3,544,248 | $100,373,000 | 3.79% |
Cormorant Asset Management, LP | 1,788,643 | $50,654,000 | 2.02% |
RA Capital Management | 1,119,963 | $31,717,000 | 0.96% |
Redmile Group, LLC | 1,020,778 | $28,908,000 | 0.69% |
SPHERA FUNDS MANAGEMENT LTD. | 256,380 | $7,261,000 | 0.60% |
GILDER GAGNON HOWE & CO LLC | 1,826,890 | $51,738,000 | 0.54% |
Perceptive Advisors | 671,978 | $19,030,000 | 0.38% |
Casdin Capital, LLC | 130,000 | $3,682,000 | 0.34% |
Granite Point Capital Management, L.P. | 13,200 | $374,000 | 0.06% |